Literature DB >> 14643086

Raclopride studies of dopamine release: dependence on presynaptic integrity.

Doris J Doudet1, James E Holden.   

Abstract

BACKGROUND: Raclopride and dopamine (DA) compete for in vivo binding to the D(2) receptors. Thus, measurements of raclopride binding provide a method to evaluate endogenous release in a variety of conditions. Amphetamine elicits DA release, provoking a rapid increase in synaptic DA and leading to a reduction in raclopride binding, which outlasts the temporary increase in extracellular DA concentrations by several hours. The mechanism responsible for the decrease in raclopride binding is still unclear.
METHODS: We used a multiple ligand concentration receptor assay method in normal monkeys and in monkeys with varying degrees of lesion of the DA nigrostriatal terminals to measure the density and affinity of D(2) receptors after methamphetamine challenge.
RESULTS: The reduced raclopride binding can be accounted for by a decreased affinity of the ligand to the receptors. There is a direct, nonlinear relationship between the presynaptic storage capacity and the change in raclopride binding after methamphetamine.
CONCLUSIONS: This observation may bear important implications for the understanding of diseases such as schizophrenia in which the marked increase in amphetamine-induced displacement of raclopride compared with normal control subjects suggests increased release of DA from presynaptic stores and potential abnormalities in presynaptic DA function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14643086     DOI: 10.1016/s0006-3223(03)00288-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  8 in total

1.  Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.

Authors:  Kristina Simonyan; Brian D Berman; Peter Herscovitch; Mark Hallett
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 2.  Imaging the dopamine system with in vivo [11C]raclopride displacement studies: understanding the true mechanism.

Authors:  Nathalie Ginovart
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

3.  Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates.

Authors:  Anne M Landau; M Mallar Chakravarty; Campbell M Clark; Athanasios P Zis; Doris J Doudet
Journal:  Neuropsychopharmacology       Date:  2010-10-13       Impact factor: 7.853

Review 4.  Striatal ups and downs: their roles in vulnerability to addictions in humans.

Authors:  Marco Leyton; Paul Vezina
Journal:  Neurosci Biobehav Rev       Date:  2013-01-16       Impact factor: 8.989

5.  Latent-Profile Analysis Reveals Behavioral and Brain Correlates of Dopamine-Cognition Associations.

Authors:  Martin Lövdén; Nina Karalija; Micael Andersson; Anders Wåhlin; Jan Axelsson; Ylva Köhncke; Lars S Jonasson; Anna Rieckman; Goran Papenberg; Douglas D Garrett; Marc Guitart-Masip; Alireza Salami; Katrine Riklund; Lars Bäckman; Lars Nyberg; Ulman Lindenberger
Journal:  Cereb Cortex       Date:  2018-11-01       Impact factor: 5.357

6.  The nature of dopamine dysfunction in schizophrenia and what this means for treatment.

Authors:  Oliver D Howes; Joseph Kambeitz; Euitae Kim; Daniel Stahl; Mark Slifstein; Anissa Abi-Dargham; Shitij Kapur
Journal:  Arch Gen Psychiatry       Date:  2012-08

Review 7.  Dopamine receptor mapping with PET imaging in Parkinson's disease.

Authors:  Flavia Niccolini; Paul Su; Marios Politis
Journal:  J Neurol       Date:  2014-03-15       Impact factor: 4.849

8.  Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson's disease.

Authors:  Andrew D Lawrence; David J Brooks; Alan L Whone
Journal:  Front Psychol       Date:  2013-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.